RU2012126104A - PHARMACEUTICAL COMPOSITION HAVING ANTI-THROMBOTIC, THROMBOLYTIC, IMMUNOMODULATING, ANTI-INFLAMMATORY ACTIONS, NORMALIZING LIPID AND CARBOHYDRATE EXCHANGE - Google Patents

PHARMACEUTICAL COMPOSITION HAVING ANTI-THROMBOTIC, THROMBOLYTIC, IMMUNOMODULATING, ANTI-INFLAMMATORY ACTIONS, NORMALIZING LIPID AND CARBOHYDRATE EXCHANGE Download PDF

Info

Publication number
RU2012126104A
RU2012126104A RU2012126104/15A RU2012126104A RU2012126104A RU 2012126104 A RU2012126104 A RU 2012126104A RU 2012126104/15 A RU2012126104/15 A RU 2012126104/15A RU 2012126104 A RU2012126104 A RU 2012126104A RU 2012126104 A RU2012126104 A RU 2012126104A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
composition according
thrombolytic
immunomodulating
thrombotic
Prior art date
Application number
RU2012126104/15A
Other languages
Russian (ru)
Other versions
RU2519741C2 (en
Inventor
Изольда Парфирьевна Баскова
Николай Константинович Желтухин
София Яковлевна Скачилова
Валентина Гавриловна Копыльцова
Ирина Алексеевна Тимохина
Александр Викторович Базин
Original Assignee
Общество с ограниченной ответственностью Научно-внедренческая фирма "Гируд И.Н." (ООО НВФ "Гируд И.Н.")
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью Научно-внедренческая фирма "Гируд И.Н." (ООО НВФ "Гируд И.Н.") filed Critical Общество с ограниченной ответственностью Научно-внедренческая фирма "Гируд И.Н." (ООО НВФ "Гируд И.Н.")
Priority to RU2012126104/15A priority Critical patent/RU2519741C2/en
Publication of RU2012126104A publication Critical patent/RU2012126104A/en
Application granted granted Critical
Publication of RU2519741C2 publication Critical patent/RU2519741C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

1. Твердая дозированная фармацевтическая композиция, обладающая противотромботическим, тромболитическим, иммуномодулирующим, противовоспалительным действиями, нормализующая липидный и углеводный обмен, характеризующаяся тем, что она изготовлена из лиофилизированной медицинской пиявки.2. Фармацевтическая композиция по п.1, характеризующаяся тем, что она выполнена в виде таблетки при соотношении действующего вещества и целевых добавок, мас.%:3. Фармацевтическая композиция по п.1 или 2, характеризующаяся тем, что в качестве целевых добавок она содержит необязательно одновременно крахмал, натрия кроскармеллозу, производные целлюлозы, аэросил, соли стеариновой кислоты, при следующем соотношении компонентов, мас.%:4. Фармацевтическая композиция по п.1 или 2, характеризующаяся тем, что она покрыта кишечнорастворимой оболочкой.1. A solid dosage pharmaceutical composition with antithrombotic, thrombolytic, immunomodulatory, anti-inflammatory effects, normalizing lipid and carbohydrate metabolism, characterized in that it is made from a lyophilized medical leech. 2. The pharmaceutical composition according to claim 1, characterized in that it is made in the form of a tablet with a ratio of active substance and target additives, wt.%: 3. The pharmaceutical composition according to claim 1 or 2, characterized in that, as target additives, it optionally simultaneously contains starch, sodium croscarmellose, cellulose derivatives, aerosil, stearic acid salts, in the following ratio, wt.%: 4. The pharmaceutical composition according to claim 1 or 2, characterized in that it is coated with an enteric coating.

Claims (4)

1. Твердая дозированная фармацевтическая композиция, обладающая противотромботическим, тромболитическим, иммуномодулирующим, противовоспалительным действиями, нормализующая липидный и углеводный обмен, характеризующаяся тем, что она изготовлена из лиофилизированной медицинской пиявки.1. A solid dosage pharmaceutical composition having antithrombotic, thrombolytic, immunomodulatory, anti-inflammatory effects, normalizes lipid and carbohydrate metabolism, characterized in that it is made from a lyophilized medical leech. 2. Фармацевтическая композиция по п.1, характеризующаяся тем, что она выполнена в виде таблетки при соотношении действующего вещества и целевых добавок, мас.%:2. The pharmaceutical composition according to claim 1, characterized in that it is made in the form of a tablet with a ratio of active substance and target additives, wt.%: активное веществоactive substance 5,0-40,05.0-40.0 целевые добавкиtargeted supplements 60,0-95,060.0-95.0
3. Фармацевтическая композиция по п.1 или 2, характеризующаяся тем, что в качестве целевых добавок она содержит необязательно одновременно крахмал, натрия кроскармеллозу, производные целлюлозы, аэросил, соли стеариновой кислоты, при следующем соотношении компонентов, мас.%:3. The pharmaceutical composition according to claim 1 or 2, characterized in that, as target additives, it optionally simultaneously contains starch, sodium croscarmellose, cellulose derivatives, aerosil, stearic acid salts, in the following ratio, wt.%: крахмалstarch 0,0-15,00,0-15,0 натрия кроскармеллозаcroscarmellose sodium 0,0-10,00,0-10,0 натрия хлоридsodium chloride 5,0-60,05.0-60.0 примеллозаprimellose 0,0-5,00,0-5,0 поливинилпирролидоныpolyvinylpyrrolidones 0,0-10,00,0-10,0 производные целлюлозыcellulose derivatives 0,0-50,00,0-50,0 кремния диоксид коллоидный (аэросил)silicon dioxide colloidal (aerosil) 0,0-10,00,0-10,0 соли стеариновой кислотыstearic acid salts 0,0-1,00,0-1,0 акрилизacrylization 5,0-15,05.0-15.0
4. Фармацевтическая композиция по п.1 или 2, характеризующаяся тем, что она покрыта кишечнорастворимой оболочкой. 4. The pharmaceutical composition according to claim 1 or 2, characterized in that it is coated with an enteric coating.
RU2012126104/15A 2012-06-25 2012-06-25 Pharmaceutical composition possessing antithrombotic, thrombolytic, immunomodulatory, anti-inflammatory action, normalising lipid and carbohydrate metabolism RU2519741C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012126104/15A RU2519741C2 (en) 2012-06-25 2012-06-25 Pharmaceutical composition possessing antithrombotic, thrombolytic, immunomodulatory, anti-inflammatory action, normalising lipid and carbohydrate metabolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012126104/15A RU2519741C2 (en) 2012-06-25 2012-06-25 Pharmaceutical composition possessing antithrombotic, thrombolytic, immunomodulatory, anti-inflammatory action, normalising lipid and carbohydrate metabolism

Publications (2)

Publication Number Publication Date
RU2012126104A true RU2012126104A (en) 2013-12-27
RU2519741C2 RU2519741C2 (en) 2014-06-20

Family

ID=49785966

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012126104/15A RU2519741C2 (en) 2012-06-25 2012-06-25 Pharmaceutical composition possessing antithrombotic, thrombolytic, immunomodulatory, anti-inflammatory action, normalising lipid and carbohydrate metabolism

Country Status (1)

Country Link
RU (1) RU2519741C2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2033173C1 (en) * 1992-01-31 1995-04-20 Изольда Порфирьевна Баскова Method for manufacture of preparation from medical leeches to produce antithrombotic, thrombolythic, antiatherosclerotic and hypotensive effects
GB9309509D0 (en) * 1993-05-07 1993-06-23 Merck Patent Gmbh Thrombin inhibitors
RU2201194C2 (en) * 2001-05-16 2003-03-27 Пермская государственная фармацевтическая академия Medicinal film "piyavit" for treatment of inflammatory diseases of parodontium
RU2268739C2 (en) * 2004-01-05 2006-01-27 ООО НВФ "Гируд И.Н." Therapeutic gel based on bioactive blood-sucker producing substances and method for production thereof
RU2438683C2 (en) * 2009-10-20 2012-01-10 ООО НВФ "Гируд И.Н." Method for making preparation of medicinal leech
CN101897727A (en) * 2010-06-18 2010-12-01 贵州信邦制药股份有限公司 Method for preparing traditional Chinese medicine tablets

Also Published As

Publication number Publication date
RU2519741C2 (en) 2014-06-20

Similar Documents

Publication Publication Date Title
BR112017026159A2 (en) heterocyclic erk1 and erk2 inhibitors and their use in cancer treatment
RU2011101713A (en) PHARMACEUTICAL COMPOSITION
RU2009116832A (en) COMPOSITION INCLUDING ARBIDOL IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES
RU2008113588A (en) 2-Ethyl-6-methyl-3-hydroxypyridinium hydroxybutanedioate possessing anti-ischemic, cerebroprotective, neurotropic and lipid-regulating activity, pharmaceuticals
RU2012126104A (en) PHARMACEUTICAL COMPOSITION HAVING ANTI-THROMBOTIC, THROMBOLYTIC, IMMUNOMODULATING, ANTI-INFLAMMATORY ACTIONS, NORMALIZING LIPID AND CARBOHYDRATE EXCHANGE
BR112014032627A2 (en) rebamipide prodrugs, method for producing the same, and use thereof
RU2019119405A (en) DALBAVANCIN LYOPHILIZED PHARMACEUTICAL COMPOSITIONS
RU2007117407A (en) DRINKING WATER FOR COWS
RU2015107685A (en) An immunostimulating pharmaceutical composition
RU2013130801A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASES OF JOINT AND BONE TISSUES
RU2017144206A (en) The use of the pharmaceutical composition based on the magnesium salt of aminoethanesulfonic acid with hepatoprotective activity for the prevention and treatment of hepatitis
RU2013126698A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCER OF THE STOMACH AND DUODENUM, POSSESSING IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIUM ANTIVYREMANTIME
CA3010857A1 (en) Pharmaceutical composition comprising nebivolol with improved dissolution rate
RU2008149236A (en) PHARMACEUTICAL COMPOSITION HAVING ANTI-INFLAMMATORY AND ANTIBACTERIAL ACTION (OPTIONS)
RU2010151556A (en) PHARMACEUTICAL COMPOSITION CONTAINING ENZYMES: LYSOZIM, PEROXIDASE, POVIARGOL AND LIPOSOMES, FOR LOCAL USE
RU2010127706A (en) ORAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT
BR112022006313A2 (en) PEDIATRIC SUSPENSION FORMULATION
RU2011104563A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ARTERIAL HYPERTENSION AND CONSTANT HEART FAILURE AND METHOD FOR ITS PRODUCTION
RU2010134123A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES
RU2008145723A (en) DRUG ACTIVITY MEDICINAL PRODUCT
RU2016146645A (en) PHARMACEUTICAL COMPOSITION OF 1-HYDROXY-4-CYCLOHEXYLAMINOADAMANTANE HYDROCHLORIDE AND SODIUM OF 4-HYDROXYXOXYLIC ACID, IMPROVING MENTAL AND PHYSICAL PERFORMANCE
RU2013131611A (en) MEANS FOR TREATMENT OF ENTERITIS IN ANIMALS
RU2009130213A (en) PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION
RU2015156489A (en) Pharmaceutical composition based on the mineral complex of ethylenediamidineduccinic acid
RU2012141906A (en) BACTERIOPHAGE CULTIVATION ENVIRONMENT AND PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140626